top of page
FDA Announces Revision in Presenting Risk & Efficacy Information in DTC Prescription Drug Promotion
FDA announced the availability of Final Guideline for Industry on presenting quantitative efficacy and risk information in...
Content Desk
1 min read
FDA Publishes Final Rule on Requirement for Patient Medication
FDA is proposing to amend its drug product labeling rules for Medication Guide and other information templates provided to...
Content Desk
2 min read
Update on In-Person, Face-to-Face ANDA Meeting
March 29, 2023 Recent update by #FDA: #Face-to-Face Meetings are back for ANDAs: The FDA's generic drug program will restart holding...
Content Desk
1 min read
bottom of page